US 3,974,193 AGrant
16-Fluoro Prostaglandin B.sub.2 Analogs
Issue Date:1976-08-10
•17 Claims
Abstract
Prostaglandin-type compounds with one or two fluoro substituents at the C-16 position are disclosed, with processes for making them. These compounds are useful for a variety of pharmacological purposes, including anti-ulcer, inhibition of platelet aggregation, increase of nasal patency, labor inducement at term, and wound healing.
Metadata
Assignee
- The Upjohn Company
Inventor
- Barney J. Magerlein
Application Information
Application Number:US 5519268
Filing Date:1975-02-21
Priority Date:1972-04-27
Art Unit:127
Classifications
IPC:
C07C 6138C07C 6974
Field of Search:
260468 D;514 D;408
Patent Drawings
This patent does not have any drawings.
Description
The present invention relates to prostaglandin analogs, for which the essential material constituting a disclosure thereof is incorporated by reference here from Ser. No. 551,694, filed Feb. 21, 1975, now U.S. Pat. No. 3,962,293.
Claims
I claim:
1. An optically active compound of the formula ##SPC1## Or a racemic compound of that formula and the mirror image thereof, wherein g is is an integer from 2 to 5, inclusive; wherein C.sub.n H.sub.2n is alkylene of one to 9 carbon atoms, inclusive, with one to 6 carbon atoms, inclusive, in the chain between --CFR.sub.2 -- and terminal methyl; wherein M'" is ##EQU1## or ##EQU2## wherein R.sub.7 and R.sub.8 are hydrogen or alkyl of one to 4 carbon atoms, inclusive, being the same or different; wherein R.sub.1 is hydrogen or alkyl of one to 12 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, or phenyl substituted with one, 2, or 3 chloro or alkyl of one to 4 carbon atoms, inclusive; and wherein R.sub.2 is hydrogen, methyl, ethyl, or fluoro; including the lower alkanoates thereof, and the pharmacologically acceptable salts thereof when R.sub.1 is hydrogen.
2. A compound according to claim 1 wherein M'" is ##STR1##
3. A compound according to claim 2 wherein R.sub.7 and R.sub.8 are either hydrogen or methyl, being the same or different, and at least one of R.sub.7 and R.sub.8 is methyl.
4. A compound according to claim 2 wherein R.sub.7 and R.sub.8 are hydrogen.
5. A compound according to claim 3 wherein g is 3.
6. A compound according to claim 5 wherein C.sub.n H.sub.2n has 3 carbon atoms in the chain between --CFR.sub.2 -- and terminal methyl.
7. A compound according to claim 6 wherein R.sub.2 is hydrogen.
8. A compound according to claim 7 wherein R.sub.1 is alkyl of one to 12 carbon atoms, inclusive.
9. A compound according to claim 7 wherein R.sub.1 is hydrogen.
10. 16-Fluoro-PGB.sub.2, optically active compounds according to claim 9.
11. A compound according to claim 6 wherein R.sub.2 is fluoro.
12. A compound according to claim 11 wherein R.sub.1 is alkyl of one to 12 carbon atoms, inclusive.
13. 16,16-Difluoro-PGB.sub.2, methyl ester, an optically active compound according to claim 12 wherein R.sub.1 is methyl.
14. A compound according to claim 5 wherein C.sub.n H.sub.2n has one, 2, 4, 5, or 6 carbon atoms in the chain between --CFR.sub.2 -- and terminal methyl.
15. A compound according to claim 4 wherein g is 2, 4, or 5.
16. 2a,2b-Dihomo-16,16-difluoro-PGB.sub.2, a compound according to claim 15.
17. A compound according to claim 1 wherein M'" is ##STR2##
Non-Patent Literature (1)
- nakanishi et al., JACS 81 5259 (1959).